Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human NK-1R ELISA Kit (AC3338)
Cat.#: ASET-1927
Specifications
Description Human NK-1R ELISA Kit allows for the in vitro quantitative determination of human NK-1R concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.188 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 0.313-20 ng/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1331 Rat Glutamate Receptor 1 (AMPA subtype) ELISA Kit (AC2742) Quantitative inquiry ASET-1018 Human GPRC5A ELISA Kit (AC2429) Quantitative inquiry ASET-1206 Human Substance P ELISA Kit (AC2617) Quantitative inquiry ASET-1130 Mouse Leptin ELISA Kit (AC2541) Quantitative inquiry ASET-1025 Human PINK1 ELISA Kit (AC2436) Quantitative inquiry ASET-1920 Mouse NMDAR2A ELISA Kit (AC3331) Quantitative inquiry ASET-1949 Human KCNJ14 ELISA Kit (AC3360) Quantitative inquiry ASET-1679 Human Synaptogyrin 3 ELISA Kit (AC3090) Quantitative inquiry ASET-2174 Mouse Dopamine ELISA Kit (AC3585) Quantitative inquiry ASET-1734 Mouse GDF11 ELISA Kit (AC3145) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket